#ECNeph
@arvindcanchi.bsky.social
indianjnephrol.org/an-updated-r...
#ECNeph
@arvindcanchi.bsky.social
indianjnephrol.org/an-updated-r...
Here is a Case Report showing PLA2rAb MN having Carcinoma Oesophagus
#ECNeph
@theisn.org @myadla.bsky.social @dramiliflores.bsky.social @arvindcanchi.bsky.social
Here is a Case Report showing PLA2rAb MN having Carcinoma Oesophagus
#ECNeph
@theisn.org @myadla.bsky.social @dramiliflores.bsky.social @arvindcanchi.bsky.social
#ECNeph
@theisn.org @myadla.bsky.social @dramiliflores.bsky.social @arvindcanchi.bsky.social
#ECNeph
@theisn.org @myadla.bsky.social @dramiliflores.bsky.social @arvindcanchi.bsky.social
#ECNeph
@theisn.org @myadla.bsky.social @dramiliflores.bsky.social @arvindcanchi.bsky.social @rheaultm.bsky.social
#ECNeph
@theisn.org @myadla.bsky.social @dramiliflores.bsky.social @arvindcanchi.bsky.social @rheaultm.bsky.social
2. Panel approach: Alternatively, a laboratory could employ a standard panel of antibodies for antigens that can vary depending on volume and demographics
3. Proteomic approach: Laser microdissection of MN glomeruli, followed by mass spectrometry. #ECneph
2. Panel approach: Alternatively, a laboratory could employ a standard panel of antibodies for antigens that can vary depending on volume and demographics
3. Proteomic approach: Laser microdissection of MN glomeruli, followed by mass spectrometry. #ECneph
1. Targeted approach: Perform antigen testing based on clinical disease association
Cont #ECNeph
www.kidney-international.org/article/S008...
1. Targeted approach: Perform antigen testing based on clinical disease association
Cont #ECNeph
www.kidney-international.org/article/S008...
#ECNeph
@theisn.org @myadla.bsky.social @dramiliflores.bsky.social @arvindcanchi.bsky.social
indianjnephrol.org/an-updated-r...
#ECNeph
@theisn.org @myadla.bsky.social @dramiliflores.bsky.social @arvindcanchi.bsky.social
indianjnephrol.org/an-updated-r...
Here is the proposed mechanism of malignancy associated MN. #ECneph
@dramiliflores.bsky.social @myadla.bsky.social @theisn.org
www.frontiersin.org/journals/med...
Here is the proposed mechanism of malignancy associated MN. #ECneph
@dramiliflores.bsky.social @myadla.bsky.social @theisn.org
www.frontiersin.org/journals/med...
👉 The association between malignancy and MN was first described in 1968
⚡️They also gave the 4 stages of MN
#ECNeph
@theisn.org @myadla.bsky.social @dramiliflores.bsky.social @arvindcanchi.bsky.social
👉 The association between malignancy and MN was first described in 1968
⚡️They also gave the 4 stages of MN
#ECNeph
@theisn.org @myadla.bsky.social @dramiliflores.bsky.social @arvindcanchi.bsky.social
📅 Date: 07 February
⏰ Time: 02:15 PM
Join #ISNWCN for a session on this novel and transformative topic in nephrology! @theisn.org
📅 Date: 07 February
⏰ Time: 02:15 PM
Join #ISNWCN for a session on this novel and transformative topic in nephrology! @theisn.org